Trends in population structure, antimicrobial susceptibility and resistance determinants of <i>Neisseria gonorrhoeae</i> isolates from surveillance in the Kanto region, Japan, 2017–2023
Ceftriaxone remains a reliable first-line treatment option for gonorrhoea. Ongoing surveillance is essential to detect emerging fluoroquinolone-susceptible lineages that may inform future treatment strategies.
Authors
- Akiko Kanayama Katsuse
- Sheeba Santhini Manoharan-Basil (ORCID: https://orcid.org/0000-0001-8421-5137)
- Masahiro Morita (ORCID: https://orcid.org/0000-0002-8627-084X)
- Yoshikazu Ishii (ORCID: https://orcid.org/0000-0002-1943-4648)
- Kohji Komori (ORCID: https://orcid.org/0000-0001-9659-3186)
- Chris Kenyon (ORCID: https://orcid.org/0000-0002-2557-8998)
- Izumo Kanesaka (ORCID: https://orcid.org/0000-0002-5918-2297)
- Kotaro Aoki (ORCID: https://orcid.org/0000-0002-9237-1217)
- Intetsu Kobayashi
- Kazuhiro Tateda
Institutions
- Toho University (JP)
- Planetary Systems (United States) (US)
- Infection Prevention Society (GB)
- Instituut voor Tropische Geneeskunde (BE)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1093/jacamr/dlag027
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development